The treatment of CD11b−/− mice after the establishment of the regulatory T cell (Treg)/Th17 balance by the IL-6 receptor-neutralizing antibody substantially suppressed the induction of Th17 cells and reduced arthritis severity [63]. This evidence concerns the gene ITGAM and arthritic joint disease.